Heart Failure Clinical Trials
Evaluates the clinical efficacy and safety of the IASD System II in symptomatic heart failure patients with an LV ejection fraction ≥40%, and elevated left sided filling pressures despite standard Guideline Directed Medical Therapy (GDMT).
Subinvestigator: Mitchell Saltzberg, MD; Nunzio Gaglianello, MD, Nicole Lohr, MD, PhD.
Status: Currently enrolling
Sub Category: Advanced Heart Failure